Revolution Medicines Quarterly Balance Sheet
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 189.49 -0.14%
Revolution Medicines financial position
As of Jun 30, 2026, Revolution Medicines reported total assets of $4.32 billion, up 77.9% from a year earlier against total liabilities of $1.72 billion. Shareholders' equity stood at $2.61 billion, or 60.3% of assets. The company held $815.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 11.38, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Revolution Medicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 815.43M | 440.94M | 383.75M | 217.44M | 402.44M | 333.55M | 543.06M | 201.26M | 275.71M | 288.43M | 696.15M | 358.40M |
| Short-Term Investments | 3.12B | 1.47B | 1.64B | 1.71B | 1.73B | 1.77B | 1.75B | 1.35B | 1.32B | 1.42B | 1.16B | 454.80M |
| Total Current Assets | 4.03B | 1.97B | 2.08B | 1.98B | 2.18B | 2.13B | 2.33B | 1.58B | 1.62B | 1.73B | 1.88B | 824.47M |
| Property, Plant & Equipment | 34.61M | 31.48M | 33.19M | 32.93M | 33.05M | 27.15M | 24.29M | 24.81M | 25.28M | 23.70M | 22.86M | 20.29M |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Intangible Assets | 55.80M | 55.80M | 55.80M | 55.87M | 56.14M | 56.40M | 56.67M | 56.94M | 57.20M | 57.47M | 57.74M | 58.01M |
| Total Assets | 4.32B | 2.25B | 2.35B | 2.25B | 2.43B | 2.37B | 2.56B | 1.76B | 1.81B | 1.91B | 2.06B | 984.23M |
| Accounts Payable | 88.42M | 80.54M | 64.62M | 74.85M | 56.76M | 47.51M | 54.43M | 24.46M | 29.32M | 32.38M | 61.79M | 29.63M |
| Total Current Liabilities | 354.06M | 289.60M | 290.42M | 245.62M | 184.53M | 158.60M | 163.91M | 110.86M | 105.33M | 93.72M | 143.85M | 85.54M |
| Total Liabilities | 1.72B | 753.82M | 723.21M | 655.02M | 564.20M | 287.20M | 293.10M | 196.69M | 189.59M | 182.90M | 235.51M | 146.77M |
| Shareholders' Equity | 2.61B | 1.50B | 1.63B | 1.60B | 1.87B | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B | 1.83B | 837.46M |
| Retained Earnings | -3.97B | -3.32B | -2.87B | -2.50B | -2.20B | -1.95B | -1.74B | -1.54B | -1.39B | -1.25B | -1.14B | -976.17M |
| Net Cash (Debt) | 3.94B | 1.91B | 2.03B | 1.93B | 2.14B | 2.10B | 2.29B | 1.55B | 1.59B | 1.70B | 1.85B | 813.20M |
| Shares Outstanding | 214.24M | 200.18M | 197.00M | 189.71M | 186.90M | 186.26M | 185.90M | 167.75M | 165.65M | 164.91M | 164.67M | 109.45M |
This table shows 12 quarterly periods of Revolution Medicines's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow RVMD's reporting calendar. What is a balance sheet?